PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Mansour Fatmah A.¹,Al-Mazrou Amer¹,Al-Mohanna Falah²,Al-Alwan Monther¹³,Ghebeh Hazem¹³^ORCID

Affiliation:

1. Stem Cell & Tissue Re-engineering Program, Research Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

2. Department of Comparative Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

3. College of Medicine, Al-Faisal University, Riyadh, Saudi Arabia

Funder

King Abdulaziz City for Science and Technology

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1729299

Reference55 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7-34.

2. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

3. Metastatic breast cancer: an updating

4. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD44/PD-L1-mediated networks in drug resistance and immune evasion of breast cancer stem cells: Promising targets of natural compounds;International Immunopharmacology;2024-09

2. Epigenetic control of immunoevasion in cancer stem cells;Trends in Cancer;2024-09

3. Modulation of PD-L1 by Astragalus polysaccharide attenuates the induction of melanoma stem cell properties and overcomes immune evasion;BMC Cancer;2024-08-21

4. Exploring the interplay between triple‐negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies;Journal of Cellular Physiology;2024-05-28

5. Neem Leaf Glycoprotein Disrupts Exhausted CD8+ T-Cell–Mediated Cancer Stem Cell Aggression;Molecular Cancer Research;2024-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3